Literature DB >> 12517958

The GTP-binding domain of class II transactivator regulates its nuclear export.

Aparna Raval1, Jocelyn D Weissman, T Kevin Howcroft, Dinah S Singer.   

Abstract

The transcriptional coactivator class II transactivator (CIITA), although predominantly localized in the nucleus, is also present in the cytoplasm. The subcellular distribution of CIITA is actively regulated by the opposing actions of nuclear export and import. In this study, we show that nuclear export is negatively regulated by the GTP-binding domain (GBD; aa 421-561) of CIITA: mutation or deletion of the GBD markedly increased export of CIITA from the nucleus. Remarkably, a CIITA GBD mutant binds CRM1/exportin significantly better than does wild-type CIITA, leading to the conclusion that GTP is a negative regulator of CIITA nuclear export. We also report that, in addition to the previously characterized N- and C-terminal nuclear localization signal elements, there is an additional N-terminal nuclear localization activity, present between aa 209 and 222, which overlaps the proline/serine/threonine-rich domain of CIITA. Thus, fine-tuning of the nucleocytoplasmic distribution of coactivator proteins involved in transcription is an active and dynamic process that defines a novel mechanism for controlling gene regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517958     DOI: 10.4049/jimmunol.170.2.922

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  NLRC5: a newly discovered MHC class I transactivator (CITA).

Authors:  Torsten B Meissner; Amy Li; Koichi S Kobayashi
Journal:  Microbes Infect       Date:  2011-12-22       Impact factor: 2.700

2.  Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.

Authors:  Giovanna Tosi; Elisabetta Pilotti; Lorenzo Mortara; Andrea De Lerma Barbaro; Claudio Casoli; Roberto S Accolla
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

3.  Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.

Authors:  Gregory R Robbins; Agnieszka D Truax; Beckley K Davis; Lu Zhang; W June Brickey; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Stable protein, unstable plaque?

Authors:  Nicholas E S Sibinga
Journal:  J Mol Cell Cardiol       Date:  2008-12-03       Impact factor: 5.000

5.  The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.

Authors:  Greta Forlani; Rawan Abdallah; Roberto S Accolla; Giovanna Tosi
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

Review 6.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

7.  Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity.

Authors:  Katherine C Soe; Ballachanda N Devaiah; Dinah S Singer
Journal:  Biochim Biophys Acta       Date:  2013-09-13

8.  Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.

Authors:  Lilien N Voong; Allison R Slater; Sebila Kratovac; Drew E Cressman
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

9.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

10.  Three novel downstream promoter elements regulate MHC class I promoter activity in mammalian cells.

Authors:  Namhoon Lee; Shankar S Iyer; Jie Mu; Jocelyn D Weissman; Anat Ohali; T Kevin Howcroft; Brian A Lewis; Dinah S Singer
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.